iXCells Biotechnologies
PrivateLast Round
Growth Equity
Sep 29, 2022
Company Overview
iXCells Biotechnologies is a biotechnology company that provides preclinical drug discovery solutions with a focus on disease-relevant cellular models, enabling technologies, and services to the academic, biotech, and pharma communities.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iXCells Biotechnologies Comparables
Compare iXCells Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axol Bioscience | 88% | |
| Allele Biotechnology and Pharmaceuticals, Inc. | 81% | |
| BrainXell | 81% |
iXCells Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Sep 29, 2022 |
iXCells Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Great Point Partners | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 64% MoM, from 9.7K to 15.9K.
- Jan 19, 2026
Monthly visitors increased 57% MoM.
iXCells Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about iXCells Biotechnologies's valuation, stock price, and market status.
Is iXCells Biotechnologies a public or private company?
iXCells Biotechnologies is a private company.
What is the current stock price of iXCells Biotechnologies?
iXCells Biotechnologies is a private company with no public stock price. Caplight tracks iXCells Biotechnologies's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is iXCells Biotechnologies worth (valuation)?
Valuation information for iXCells Biotechnologies is not publicly available.
Can I buy iXCells Biotechnologies stock?
iXCells Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was iXCells Biotechnologies's last funding round?
iXCells Biotechnologies's most recent funding round was Growth Equity on September 29, 2022.
Who are the main investors in iXCells Biotechnologies?
Key investors in iXCells Biotechnologies include Great Point Partners.
Will iXCells Biotechnologies IPO soon?
No public IPO plans have been announced for iXCells Biotechnologies.
How can I track iXCells Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor iXCells Biotechnologies's secondary market activity and sign up for updates.